{"disease":{"id":"endstage-renal-disease","name":"endstage renal disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03020303","title":"Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2538,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT02946229","title":"Data Collection for Next Generation Ultrasound Technology Development","phase":"NA","overall_status":"COMPLETED","enrollment_count":142,"lead_sponsor_name":"GE Healthcare","has_results":true},{"nct_id":"NCT03010072","title":"The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Prim. Priv. Doz. Dr. Daniel Cejka","has_results":false},{"nct_id":"NCT02981706","title":"Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Columbia University","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}